{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:25Z","timestamp":1786979965543,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05515-y","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T03:02:58Z","timestamp":1703818978000},"page":"291-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3584-2788","authenticated-orcid":false,"given":"Mehmet Tuncay","family":"Duru\u00f6z","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3570-3825","authenticated-orcid":false,"given":"\u015eebnem","family":"Ataman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3008-7007","authenticated-orcid":false,"given":"Hatice","family":"Bodur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4838-1650","authenticated-orcid":false,"given":"Hasan Fatih","family":"\u00c7ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7519-9470","authenticated-orcid":false,"given":"Meltem Alkan","family":"Meliko\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3012-2968","authenticated-orcid":false,"given":"\u00d6zg\u00fcr","family":"Akg\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2728-5934","authenticated-orcid":false,"given":"Erhan","family":"\u00c7apk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8287-2264","authenticated-orcid":false,"given":"G\u00fclcan","family":"G\u00fcrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-1586","authenticated-orcid":false,"given":"Remzi","family":"\u00c7evik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0921-5991","authenticated-orcid":false,"given":"Feride Nur","family":"G\u00f6\u011f\u00fc\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-7250","authenticated-orcid":false,"given":"Ayhan","family":"Kamanl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8630-9233","authenticated-orcid":false,"given":"Fatma G\u00fcl","family":"Yurdakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5988-7369","authenticated-orcid":false,"given":"I\u0307lker","family":"Ya\u011fc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5852-3854","authenticated-orcid":false,"given":"Aylin","family":"Rezvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6453-8382","authenticated-orcid":false,"given":"Lale","family":"Altan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"5515_CR1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.12688\/f1000research.112921.1","volume":"11","author":"R Raj","year":"2022","unstructured":"Raj R, Thomas S, Gorantla V (2022) Accelerated atherosclerosis in rheumatoid arthritis: a systematic review. F1000Res 11:466. https:\/\/doi.org\/10.12688\/f1000research.112921.1","journal-title":"F1000Res"},{"key":"5515_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222259","author":"C Charles-Schoeman","year":"2022","unstructured":"Charles-Schoeman C, Buch MH, Dougados M, Bhatt DL, Giles JT, Ytterberg SR, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Rivas JL, Yndestad A, Connell CA, Szekanecz Z (2022) Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2022-222259","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5515_CR3","doi-asserted-by":"publisher","first-page":"e28501","DOI":"10.1097\/MD.0000000000028501","volume":"101","author":"KH Yu","year":"2022","unstructured":"Yu KH, Chen HH, Cheng TT, Jan YJ, Weng MY, Lin YJ, Chen HA, Cheng JT, Huang KY, Li KJ, Su YJ, Leong PY, Tsai WC, Lan JL, Chen DY (2022) Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis. Medicine (Baltimore) 101(1):e28501. https:\/\/doi.org\/10.1097\/MD.0000000000028501","journal-title":"Medicine (Baltimore)"},{"key":"5515_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223050","author":"V Molander","year":"2022","unstructured":"Molander V, Bower H, Frisell T, Delcoigne B, Di Giuseppe D, Askling J (2022) ARTIS study group. Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2022-223050","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5515_CR5","doi-asserted-by":"publisher","first-page":"100380","DOI":"10.1016\/j.ajpc.2022.100380","volume":"14","author":"A Aronov","year":"2022","unstructured":"Aronov A, Kim YJ, Sweiss NJ, Nazir NT (2022) Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis. Am J Prev Cardiol 14(12):100380. https:\/\/doi.org\/10.1016\/j.ajpc.2022.100380","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"5515_CR6","doi-asserted-by":"publisher","first-page":"13698","DOI":"10.1038\/s41598-022-18128-5","volume":"12","author":"C Almeida-Santiago","year":"2022","unstructured":"Almeida-Santiago C, Quevedo-Abeledo JC, Hern\u00e1ndez-Hern\u00e1ndez V, de Vera-Gonz\u00e1lez A, Gonzalez-Delgado A, Gonz\u00e1lez-Gay M\u00c1, Ferraz-Amaro I (2022) Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis. Sci Rep 12(1):13698. https:\/\/doi.org\/10.1038\/s41598-022-18128-5","journal-title":"Sci Rep"},{"issue":"6","key":"5515_CR7","doi-asserted-by":"publisher","first-page":"e0269431","DOI":"10.1371\/journal.pone.0269431","volume":"17","author":"G Dessie","year":"2022","unstructured":"Dessie G (2022) Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa. PLoS ONE 17(6):e0269431. https:\/\/doi.org\/10.1371\/journal.pone.0269431","journal-title":"PLoS ONE"},{"issue":"10","key":"5515_CR8","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3390\/jcm11102704","volume":"11","author":"B Dijkshoorn","year":"2022","unstructured":"Dijkshoorn B, Raadsen R, Nurmohamed MT (2022) Cardiovascular disease risk in rheumatoid arthritis anno 2022. J Clin Med 11(10):2704. https:\/\/doi.org\/10.3390\/jcm11102704","journal-title":"J Clin Med"},{"key":"5515_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10557-022-07387-z","volume":"5","author":"A Cordova Sanchez","year":"2022","unstructured":"Cordova Sanchez A, Khokhar F, Olonoff DA, Carhart RL (2022) Hydroxychloroquine and cardiovascular events in patients with rheumatoid arthritis. Cardiovasc Drugs Ther 5:1\u20138. https:\/\/doi.org\/10.1007\/s10557-022-07387-z","journal-title":"Cardiovasc Drugs Ther"},{"issue":"10","key":"5515_CR10","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1007\/s10067-023-06587-8","volume":"42","author":"G Gerganov","year":"2023","unstructured":"Gerganov G, Georgiev T, Dimova M, Shivacheva T (2023) Vascular effects of biologic and targeted synthetic antirheumatic drugs approved for rheumatoid arthritis: a systematic review. Clin Rheumatol 42(10):2651\u20132676. https:\/\/doi.org\/10.1007\/s10067-023-06587-8","journal-title":"Clin Rheumatol"},{"issue":"7","key":"5515_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/acr2.11432","volume":"4","author":"K Yoshida","year":"2022","unstructured":"Yoshida K, Harrold LR, Middaugh N, Guan H, Stryker S, Karis E, Solomon DH (2022) Time-varying association of rheumatoid arthritis disease activity to subsequent cardiovascular risk. ACR Open Rheumatol 4(7):587\u2013595. https:\/\/doi.org\/10.1002\/acr2.11432","journal-title":"ACR Open Rheumatol"},{"issue":"4","key":"5515_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2109927","volume":"386","author":"SR Ytterberg","year":"2022","unstructured":"Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA (2022) ORAL surveillance investigators. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N Engl J Med 386(4):316\u2013326. https:\/\/doi.org\/10.1056\/NEJMoa2109927","journal-title":"N Engl J Med"},{"key":"5515_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10067-022-06335-4","volume":"16","author":"JD Guerra","year":"2022","unstructured":"Guerra JD, De Santiago AB, Reed S, Hammonds KP, Shaver C, Widmer RJ, Scholz BA (2022) Cardiology co-management of rheumatoid arthritis patients with coronary artery disease as an intervention reduces hospitalization rates and adverse event occurrence. Clin Rheumatol 16:1\u201310. https:\/\/doi.org\/10.1007\/s10067-022-06335-4","journal-title":"Clin Rheumatol"},{"issue":"9","key":"5515_CR14","doi-asserted-by":"publisher","first-page":"931626","DOI":"10.3389\/fmed.2022.931626","volume":"29","author":"P Wen","year":"2022","unstructured":"Wen P, Luo P, Zhang B, Wang Y, Hao L, Wang J, Guo J, Liu R, Zhang Y, Chen J (2022) Hotspots and future directions in rheumatoid arthritis-related cardiovascular disease: a scientometric and visualization study from 2001 to 2021 based on Web of Science. Front Med (Lausanne) 29(9):931626. https:\/\/doi.org\/10.3389\/fmed.2022.931626","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"5515_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/annrheumdis-2021-221996","volume":"81","author":"B Delcoigne","year":"2022","unstructured":"Delcoigne B, Ljung L, Provan SA, Glintborg B, Hetland ML, Gr\u00f8n KL, Peltomaa R, Relas H, Turesson C, Gudbjornsson B, Michelsen B, Askling J (2022) Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries. Ann Rheum Dis 81(6):789\u2013797. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221996","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5515_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.31138\/mjr.33.2.201","volume":"33","author":"AG Semb","year":"2022","unstructured":"Semb AG, Ikdahl E, Kerola AM, Wibetoe G, Sexton J, Crowson CS, van Riel P, Kitas G, Graham I, Rollefstad S (2022) SURF-RA collaborators. A clinical audit of cardiovascular risk factors and disease in patients with rheumatoid arthritis\u2014SURF-RA. Mediterr J Rheumatol 33(2):201\u2013217. https:\/\/doi.org\/10.31138\/mjr.33.2.201","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"5515_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13075-022-02722-z","volume":"24","author":"H Gouze","year":"2022","unstructured":"Gouze H, Aegerter P, Said-Nahal R, Zins M, Goldberg M, Morelle G, Schett G, Breban M, D\u2019Agostino MA (2022) Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events. Arthritis Res Ther 24(1):56. https:\/\/doi.org\/10.1186\/s13075-022-02722-z","journal-title":"Arthritis Res Ther"},{"key":"5515_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac210","author":"AM Kerola","year":"2022","unstructured":"Kerola AM, Kazemi A, Rollefstad S, Lillegraven S, Sexton J, Wibetoe G, Haavardsholm EA, Kvien TK, Semb AG (2022) All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keac210","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5515_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s40744-021-00403-y","volume":"9","author":"S Ataman","year":"2022","unstructured":"Ataman S, Sunar I, Bodur H, Melikoglu MA, Cay HF, Capkin E, Akgul O, Cevik R, Gogus F, Kamanli A, Yurdakul FG, Gurer G, Yagci I, Rezvani A, Duruoz MT (2022) Demographic and clinical characteristics of patients with sustained and switching treatments using biological and targeted synthetic disease-modifying antirheumatic drugs: a multicenter, observational cross-sectional study for rheumatoid arthritis. Rheumatol Ther 9(1):223\u2013241. https:\/\/doi.org\/10.1007\/s40744-021-00403-y","journal-title":"Rheumatol Ther"},{"issue":"5","key":"5515_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/ard-2022-223762","volume":"82","author":"T Frisell","year":"2023","unstructured":"Frisell T, Bower H, Morin M, Baecklund E, Di Giuseppe D, Delcoigne B, Feltelius N, Forsblad-d\u2019Elia H, Lindqvist E, Lindstr\u00f6m U, Askling J (2023) ARTIS Study group. Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme. Ann Rheum Dis 82(5):601\u2013610. https:\/\/doi.org\/10.1136\/ard-2022-223762","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5515_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/OARRR.S260426","volume":"6","author":"H Almoallim","year":"2020","unstructured":"Almoallim H, Hassan R, Cheikh M, Faruqui H, Alquraa R, Eissa A, Alhazmi A, Alsolaimani R, Janoudi N (2020) Rheumatoid arthritis saudi database (RASD): disease characteristics and remission rates in a tertiary care center. Open Access Rheumatol 6(12):139\u2013145. https:\/\/doi.org\/10.2147\/OARRR.S260426","journal-title":"Open Access Rheumatol"},{"issue":"9","key":"5515_CR22","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3899\/jrheum.200842","volume":"48","author":"E Myasoedova","year":"2021","unstructured":"Myasoedova E, Davis JM, Roger VL, Achenbach SJ, Crowson CS (2021) Improved incidence of cardiovascular disease in patients with incident rheumatoid arthritis in the 2000s: a population-based cohort study. J Rheumatol 48(9):1379\u20131387. https:\/\/doi.org\/10.3899\/jrheum.200842","journal-title":"J Rheumatol"},{"issue":"11","key":"5515_CR23","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00296-021-04992-3","volume":"41","author":"MA Melikoglu","year":"2021","unstructured":"Melikoglu MA, Ataman S, Bodur H, Cay HF, Capkin E, Akgul O, Cevik R, Gogus F, Kamanli A, Yurdakul FG, Gurer G, Yagci I, Rezvani A, Duruoz MT, Sunar I (2021) Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioSTAR. Rheumatol Int 41(11):1971\u20131978. https:\/\/doi.org\/10.1007\/s00296-021-04992-3","journal-title":"Rheumatol Int"},{"issue":"21","key":"5515_CR24","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.3390\/jcm10214975","volume":"10","author":"I Ferraz-Amaro","year":"2021","unstructured":"Ferraz-Amaro I, Corrales A, Atienza-Mateo B, Vegas-Revenga N, Prieto-Pe\u00f1a D, Blanco R, Gonz\u00e1lez-Gay M\u00c1 (2021) Moderate and high disease activity predicts the development of carotid plaque in rheumatoid arthritis patients without classic cardiovascular risk factors: six years follow-up study. J Clin Med 10(21):4975. https:\/\/doi.org\/10.3390\/jcm10214975","journal-title":"J Clin Med"},{"issue":"4","key":"5515_CR25","doi-asserted-by":"publisher","first-page":"e2021238","DOI":"10.23750\/abm.v92i4.10831","volume":"92","author":"F Salaffi","year":"2021","unstructured":"Salaffi F, Di Carlo M, Farah S, Marotto D, Atzeni F, Sarzi-Puttini P (2021) Rheumatoid Arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures. Acta Biomed 92(4):e2021238. https:\/\/doi.org\/10.23750\/abm.v92i4.10831","journal-title":"Acta Biomed"},{"issue":"6","key":"5515_CR26","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1136\/ard.2010.142901","volume":"70","author":"L Gossec","year":"2011","unstructured":"Gossec L, Paternotte S, Aanerud GJ, Balanescu A, Boumpas DT, Carmona L, de Wit M, Dijkmans BA, Dougados M, Englbrecht M, Gogus F, Heiberg T, Hernandez C, Kirwan JR, Mola EM, Cerinic MM, Otsa K, Schett G, Scholte-Voshaar M, Sokka T, von Krause G, Wells GA, Kvien TK (2011) Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis 70(6):935\u2013942. https:\/\/doi.org\/10.1136\/ard.2010.142901","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5515_CR27","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/ard.2010.143032","volume":"70","author":"T Heiberg","year":"2011","unstructured":"Heiberg T, Austad C, Kvien TK, Uhlig T (2011) Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to other patient-reported outcomes in a register of patients with rheumatoid arthritis. Ann Rheum Dis 70(6):1080\u20131082. https:\/\/doi.org\/10.1136\/ard.2010.143032","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5515_CR28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/1043659615577699","volume":"27","author":"FI Cinar","year":"2016","unstructured":"Cinar FI, Cinar M, Yilmaz S, Acikel C, Erdem H, Pay S, Simsek I (2016) Cross-cultural adaptation, reliability, and validity of the Turkish version of the compliance questionnaire on rheumatology in patients with Beh\u00e7et\u2019s disease. J Transcult Nurs 27(5):480\u2013486. https:\/\/doi.org\/10.1177\/1043659615577699","journal-title":"J Transcult Nurs"},{"issue":"6","key":"5515_CR29","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00296-011-1795-0","volume":"32","author":"E Ozcan","year":"2012","unstructured":"Ozcan E, Yilmaz O, Tutoglu A, Bodur H (2012) Validity and reliability of the Turkish version of the health assessment questionnaire for the spondyloarthropathies. Rheumatol Int 32(6):1563\u20131568. https:\/\/doi.org\/10.1007\/s00296-011-1795-0","journal-title":"Rheumatol Int"},{"issue":"1","key":"5515_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/art.20091","volume":"51","author":"AA K\u00fc\u00e7\u00fckdeveci","year":"2004","unstructured":"K\u00fc\u00e7\u00fckdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A (2004) Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum 51(1):14\u201319. https:\/\/doi.org\/10.1002\/art.20091","journal-title":"Arthritis Rheum"},{"key":"5515_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06349-y","author":"H Muhammed","year":"2022","unstructured":"Muhammed H, Misra DP, Jain N, Ganguly S, Pattanaik SS, Rai MK, Anuja AK, Mohindra N, Kumar S, Agarwal V (2022) The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-022-06349-y","journal-title":"Clin Rheumatol"},{"issue":"58","key":"5515_CR32","doi-asserted-by":"publisher","first-page":"152132","DOI":"10.1016\/j.semarthrit.2022.152132","volume":"12","author":"R Raadsen","year":"2022","unstructured":"Raadsen R, Agca R, Boers M, van Halm VP, Peters MJL, Smulders Y, Beulens JWJ, Blom MT, Stehouwer CDA, Voskuyl AE, Lems WF, Nurmohamed MT (2022) In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: a 20-year follow-up in the CARR\u00c9 cohort study. Semin Arthritis Rheum 12(58):152132. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152132","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"5515_CR33","doi-asserted-by":"publisher","first-page":"075","DOI":"10.1093\/rap\/rkac075","volume":"6","author":"K Jain","year":"2022","unstructured":"Jain K, Laila D, Nandagudi A, Bharadwaj A (2022) Long-term outcomes in rheumatoid arthritis: review of data from the \u2018Basildon inflammatory arthritis cohort.\u2019 Rheumatol Adv Pract 6(3):075. https:\/\/doi.org\/10.1093\/rap\/rkac075","journal-title":"Rheumatol Adv Pract"},{"issue":"6","key":"5515_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/acr2.11376","volume":"4","author":"RK Dore","year":"2022","unstructured":"Dore RK, Antonova JN, Burudpakdee C, Chang L, Gorritz M, Genovese MC (2022) The incidence, prevalence, and associated costs of anemia, malignancy, venous thromboembolism, major adverse cardiovascular events, and infections in rheumatoid arthritis patients by treatment history in the United States. ACR Open Rheumatol 4(6):473\u2013482. https:\/\/doi.org\/10.1002\/acr2.11376","journal-title":"ACR Open Rheumatol"},{"issue":"21","key":"5515_CR35","doi-asserted-by":"publisher","first-page":"6535","DOI":"10.3390\/jcm11216535","volume":"11","author":"H Kokkonen","year":"2022","unstructured":"Kokkonen H, Johansson L, Stenlund H, Rantap\u00e4\u00e4-Dahlqvist S (2022) Cardiovascular risk factors before onset of rheumatoid arthritis are associated with cardiovascular events after disease onset: a case\u2013control study. J Clin Med 11(21):6535. https:\/\/doi.org\/10.3390\/jcm11216535","journal-title":"J Clin Med"},{"issue":"8","key":"5515_CR36","doi-asserted-by":"publisher","first-page":"745601","DOI":"10.3389\/fmed.2021.745601","volume":"5","author":"L Argnani","year":"2021","unstructured":"Argnani L, Zanetti A, Carrara G, Silvagni E, Guerrini G, Zambon A, Scir\u00e8 CA (2021) Rheumatoid arthritis and cardiovascular risk: retrospective matched-cohort analysis based on the RECORD study of the Italian society for rheumatology. Front Med (Lausanne) 5(8):745601. https:\/\/doi.org\/10.3389\/fmed.2021.745601","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"5515_CR37","doi-asserted-by":"publisher","first-page":"e001568","DOI":"10.1136\/rmdopen-2021-001568","volume":"7","author":"AJ Landgren","year":"2021","unstructured":"Landgren AJ, Dehlin M, Jacobsson L, Bergsten U, Klingberg E (2021) Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden. RMD Open 7(2):e001568. https:\/\/doi.org\/10.1136\/rmdopen-2021-001568","journal-title":"RMD Open"},{"issue":"9","key":"5515_CR38","doi-asserted-by":"publisher","first-page":"855141","DOI":"10.3389\/fmed.2022.855141","volume":"8","author":"W Cai","year":"2022","unstructured":"Cai W, Tang X, Pang M (2022) Prevalence of metabolic syndrome in patients with rheumatoid arthritis: an updated systematic review and meta-analysis. Front Med (Lausanne) 8(9):855141. https:\/\/doi.org\/10.3389\/fmed.2022.855141","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"5515_CR39","doi-asserted-by":"publisher","first-page":"e001618","DOI":"10.1136\/rmdopen-2021-001618","volume":"7","author":"G Ozen","year":"2021","unstructured":"Ozen G, Pedro S, Schumacher R, Simon T, Michaud K (2021) Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: Do they differ in patients with rheumatoid arthritis? RMD Open 7(2):e001618. https:\/\/doi.org\/10.1136\/rmdopen-2021-001618","journal-title":"RMD Open"},{"key":"5515_CR40","doi-asserted-by":"publisher","unstructured":"Vicente GNS, Pereira IA, de Castro GRW, da Mota LMH, Carnieletto AP, de Souza DGS, da Gama FO, Santos ABV, de Albuquerque CP, B\u00e9rtolo MB, J\u00fanior PL, Giorgi RDN, Radominski SC, Guimar\u00e3es MFBR, Bonfiglioli KR, Sauma MFLDC, Brenol CV, da Rocha Castelar Pinheiro G (2021) Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study. Adv Rheumatol 61(1):38. https:\/\/doi.org\/10.1186\/s42358-021-00186-4","DOI":"10.1186\/s42358-021-00186-4"},{"issue":"6","key":"5515_CR41","doi-asserted-by":"publisher","first-page":"e26430","DOI":"10.7759\/cureus.26430","volume":"14","author":"S Nair","year":"2022","unstructured":"Nair S, Singh Kahlon S, Sikandar R, Peddemul A, Tejovath S, Hassan D, Patel KK, Mostafa JA (2022) Tumor necrosis factor-alpha inhibitors and cardiovascular risk in rheumatoid arthritis: a systematic review. Cureus 14(6):e26430. https:\/\/doi.org\/10.7759\/cureus.26430","journal-title":"Cureus"},{"issue":"8","key":"5515_CR42","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/annrheumdis-2018-214846","volume":"78","author":"W Xie","year":"2019","unstructured":"Xie W, Huang Y, Xiao S, Sun X, Fan Y, Zhang Z (2019) Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials. Ann Rheum Dis 78(8):1048\u20131054. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214846","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5515_CR43","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/acr.23875","volume":"72","author":"S Singh","year":"2020","unstructured":"Singh S, Fumery M, Singh AG, Singh N, Prokop LJ, Dulai PS, Sandborn WJ, Curtis JR (2020) Comparative risk of cardiovascular events with biologic and synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 72(4):561\u2013576. https:\/\/doi.org\/10.1002\/acr.23875","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"16","key":"5515_CR44","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.3390\/jcm11164841","volume":"11","author":"C Jesson","year":"2022","unstructured":"Jesson C, Bohbot Y, Soudet S, Renard C, Sobhy Danial JM, Diep L, Doussi\u00e8re M, Tribouilloy C, Go\u00ebb V (2022) Is the calcium score useful for rheumatoid arthritis patients at low or intermediate cardiovascular risk? J Clin Med 11(16):4841. https:\/\/doi.org\/10.3390\/jcm11164841","journal-title":"J Clin Med"},{"key":"5515_CR45","doi-asserted-by":"publisher","unstructured":"Metsios GS, Moe RH, van der Esch M, van Zanten JJCSV, Fenton SAM, Koutedakis Y, Vitalis P, Kennedy N, Brodin N, Bostrom C, Swinnen TW, Tzika K, Niedermann K, Nikiphorou E, Fragoulis GE, Vlieland TPVM, Van den Ende CHM, Kitas GD, IMPACT-RMD Consortium (2020) The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis. Rheumatol Int 40(3):347\u2013357. https:\/\/doi.org\/10.1007\/s00296-019-04483-6","DOI":"10.1007\/s00296-019-04483-6"},{"key":"5515_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05492-2","author":"BI Coskun","year":"2023","unstructured":"Coskun BI (2023) Exercise therapy for improving cardiovascular health in rheumatoid arthritis. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-023-05492-2","journal-title":"Rheumatol Int"},{"issue":"6","key":"5515_CR47","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s10067-020-04937-4","volume":"39","author":"M Azeez","year":"2020","unstructured":"Azeez M, Clancy C, O\u2019Dwyer T, Lahiff C, Wilson F, Cunnane G (2020) Benefits of exercise in patients with rheumatoid arthritis: a randomized controlled trial of a patient-specific exercise programme. Clin Rheumatol 39(6):1783\u20131792. https:\/\/doi.org\/10.1007\/s10067-020-04937-4","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05515-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T08:05:20Z","timestamp":1705565120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05515-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["5515"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05515-y","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]},"assertion":[{"value":"23 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all subjects before enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}